ANMAT prohibits the sale and use of an anti-cancer drug

The national administration of drugs, food and medical technology, ANMAT, prohibits the sale and use of a drug used in various cancer treatments. It's about "Keytruda, Pembrolizumab 100 mg / 4 ml solution for infusion with 1 vial of 4 ml solution for injection."